Search Results - "Lorgeot, Valérie"
-
1
Plasma levels and metabolism of AcSDKP in patients with chronic renal failure: Relationship with erythropoietin requirements
Published in American journal of kidney diseases (01-09-2001)“…N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) is a physiological inhibitor of hematopoiesis that is maintained at stable levels in normal plasma. Its…”
Get full text
Journal Article -
2
Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection
Published in Nephrology, dialysis, transplantation (01-07-2004)“…Background. Macrophage-colony stimulating factor (M-CSF) is the principal factor for survival of monocytes and macrophages that play an important role in…”
Get full text
Journal Article -
3
-
4
Whole blood production of monocytic cytokines (IL-1β, IL-6, TNF-α, sIL-6R, IL-1Ra) in haemodialysed patients
Published in Nephrology, dialysis, transplantation (01-10-1999)“…Background. The production of monocytic cytokines by isolated mononuclear cells after stimulation by phytohaemagglutinin (PHA) and lipopolysaccharide (LPS) is…”
Get full text
Journal Article Conference Proceeding -
5
Cyclosporin A inhibition of macrophage colony-stimulating factor (M-CSF) production by activated human T lymphocytes
Published in Journal of leukocyte biology (01-02-2002)“…M‐CSF is a pleiotropic cytokine involved in the survival, proliferation, and differentiation of cells of the monocyte/macrophagelineage. M‐CSF is produced by…”
Get full text
Journal Article -
6
Angiotensin-converting enzyme inhibitors and anemia in chronic kidney disease: A complex interaction: In reply
Published in American journal of kidney diseases (01-04-2002)Get full text
Journal Article -
7
Gender differences in responsiveness to erythropoietin: In Reply
Published in American journal of kidney diseases (01-02-2002)Get full text
Journal Article -
8
Angiotensin-converting enzyme inhibitors and anemia in chronic kidney disease: A complex interaction
Published in American journal of kidney diseases (01-04-2002)Get full text
Journal Article -
9
Plasma leukaemia inhibitory factor, interleukin 6 and soluble interleukin 6 receptor levels during cardiopulmonary bypass with extracorporeal circulation
Published in Cytokine (Philadelphia, Pa.) (01-04-1998)“…In this study the authors assessed plasma leukaemia inhibitory factor (LIF), interleukin 6 (IL-6) and soluble IL-6 receptor (sIL-6R) concentrations in 28…”
Get full text
Journal Article -
10
PLASMA LEUKAEMIA INHIBITORY FACTOR, INTERLUEKIN 6 AND SOLUBLE INTERLEUKIN 6 RECEPTOR LEVELS DURING CARDIOPULMONARY BYPASS WITH EXTRACORPOREAL CIRCULATION
Published in Cytokine (Philadelphia, Pa.) (01-04-1998)“…In this study the authors assessed plasma leukaemia inhibitory factor (LIF), interleukin 6 (IL-6) and soluble IL-6 receptor (sIL-6R) concentrations in 28…”
Get full text
Journal Article -
11
The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy
Published in European cytokine network (Montrouge) (01-12-1998)“…The specific binding of leukemia inhibitory factor (LIF) or oncostatin-M (OSM) to transmembrane gp190 or gp130 leads to their oligomerization which is…”
Get more information
Journal Article -
12
DEVELOPMENT OF ENZYMO-IMMUNOASSAYS (EIA) FOR MACROPHAGE COLONY-STIMULATING-FACTOR (M-CSF) AND LEUKAEMIA INHIBITORY FACTOR (LIF) BY USING THE SAME CAPTURE AND SIGNAL GENERATING POLYCLONAL ANTIBODY
Published in Cytokine (Philadelphia, Pa.) (01-07-1996)“…Specific high titre polyclonal antibodies rapidly obtained by intralymphnode immunization of rabbits with recombinant M-CSF and LIF (<60 μg/animal) have been…”
Get full text
Journal Article -
13
AcSDKP plasma concentrations in patients with solid tumours: comparison of two chemotherapeutic regimens
Published in Cancer letters (15-01-1997)“…The tetrapeptide AcSer-Asp-Lys-Pro (AcSDKP) is a physiological inhibitor of the proliferation of haematopoietic stem cells and progenitors. In Ara-C-treated…”
Get full text
Journal Article